Immunotherapy's Great Potential for Ovarian Cancer
More research is necessary and would be beneficial
This shows that there is great interest how checkpoint inhibitors can help to treat ovarian cancer. Regardless of the little data available to date, professor Ledermann recommends advancing immunotherapy by incessantly enrolling patients in clinical trials. Instead of giving immunotherapy to every single patient, it is first necessary to understand which drugs are active in which particular group of patients and why.
